Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A.
about
Functional domains of transcription factor hGABP beta1/E4TF1-53 required for nuclear localization and transcription activationComponents of Adenovirus Genome PackagingSynergistic transcriptional activation by hGABP and select members of the activation transcription factor/cAMP response element-binding protein familyRegional mapping of two subunits of transcription factor E4TF1 to human chromosomeThe L4 22-kilodalton protein plays a role in packaging of the adenovirus genomeRaf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.Bipartite structure and functional independence of adenovirus type 5 packaging elements.The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation.Characterization of a hepatoma mRNA transcribed from a third promoter of a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-encoding gene and controlled by ets oncogene-related products.A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivationFunctional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer IAdenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression.Transcriptional activation through the tetrameric complex formation of E4TF1 subunits.Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation.
P2860
Q24544060-4CAF9B4B-AE85-4BCA-8D67-36BE2DEE7B82Q28072356-73337F38-6BCE-43A1-9066-91261692AE37Q28139476-8D81F428-95AA-4B0E-B5FD-68FB0EA0FEFDQ28300845-29416A9B-574C-484D-940A-AD923B6883D0Q34717916-FC11154F-A428-4AD8-92D2-CB97422858A5Q35858687-3F4700F3-7B33-4ABB-8268-40EDBD68A74CQ35882126-9A7F5992-B54D-4DC1-B7FB-A5D1B1A2387EQ35886186-37C617F9-B707-4036-86C6-9333079A479CQ36517929-B809822A-3D56-4CB6-AB28-85B9253D5F41Q36555110-AFC66568-D2DC-423C-82A1-42D81A2C79FDQ36558883-C72FA74F-4817-4BC8-94D4-53F8F89B2FCFQ38317843-42A8524C-89E9-43FF-A64B-05245295EF27Q39877707-BD09FD66-645C-493D-9BEF-AE81B2F52A3DQ40791251-362EC93E-4BD9-4F81-AAE1-F2763E4D746AQ42828596-ABCA8339-140E-4B92-A77A-6868798AE2E8
P2860
Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Different binding site require ...... partite enhancer factor EF-1A.
@ast
Different binding site require ...... partite enhancer factor EF-1A.
@en
type
label
Different binding site require ...... partite enhancer factor EF-1A.
@ast
Different binding site require ...... partite enhancer factor EF-1A.
@en
prefLabel
Different binding site require ...... partite enhancer factor EF-1A.
@ast
Different binding site require ...... partite enhancer factor EF-1A.
@en
P2093
P2860
P356
P1476
Different binding site require ...... partite enhancer factor EF-1A.
@en
P2093
P2860
P304
P356
10.1093/NAR/20.24.6555
P407
P577
1992-12-01T00:00:00Z